China Universal Asset Management Co., Ltd. Dyne Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 21,575 shares of DYN stock, worth $260,626. This represents 0.05% of its overall portfolio holdings.
Number of Shares
21,575
Previous 19,310
11.73%
Holding current value
$260,626
Previous $693,000
26.7%
% of portfolio
0.05%
Previous 0.08%
Shares
15 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$96.9 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$89.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$89.1 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$81 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$77.1 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $625M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...